NeueHealth (NYSE:NEUE) Director Sells $26,426.25 in Stock

Key Points

• NeueHealth Director Carmen Chang sold 3,915 shares of the company's stock for a total of $26,426.25 at an average price of $6.75, reducing ownership by 0.79%.
• The company reported ($1.68) earnings per share for the last quarter, which was better than the analyst estimate of ($4.77), but revenue fell short of expectations at $209.08 million.
• New stakeholder PenderFund Capital Management Ltd. acquired 29,115 shares, increasing institutional ownership of NeueHealth to 63.88%.

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) Director Carmen Chang sold 3,915 shares of the firm's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $6.75, for a total transaction of $26,426.25. Following the completion of the transaction, the director owned 488,702 shares of the company's stock, valued at approximately $3,298,738.50. The trade was a 0.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

NeueHealth Stock Performance

NEUE stock remained flat at $6.75 during midday trading on Monday. NeueHealth, Inc. has a 12 month low of $3.79 and a 12 month high of $7.66. The stock has a market capitalization of $60.94 million, a price-to-earnings ratio of -0.42 and a beta of 0.59. The company's fifty day simple moving average is $6.72 and its 200 day simple moving average is $6.72.

NeueHealth (NYSE:NEUE - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($1.68) earnings per share for the quarter, topping analysts' consensus estimates of ($4.77) by $3.09. The business had revenue of $209.08 million for the quarter, compared to analyst estimates of $249.50 million. Equities analysts predict that NeueHealth, Inc. will post -9.13 EPS for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NeueHealth stock. PenderFund Capital Management Ltd. bought a new stake in NeueHealth, Inc. (NYSE:NEUE - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 29,115 shares of the company's stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned about 0.33% of NeueHealth as of its most recent SEC filing. 63.88% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a "sell (e+)" rating on shares of NeueHealth in a research report on Saturday, September 27th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, NeueHealth currently has an average rating of "Reduce" and an average target price of $7.00.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.